(Q45949632)
Statements
Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy (English)
Walter Klepetko
Peter Jaksch
Barbara Zweytick
Ali Mir Hoda
Maya Keplinger
scientific article published on 13 May 2009